FDA approves standalone use of J&J’s ketamine-derived depression treatment
CNN   17 hours ago
ads
Read Full Story
FDA approves standalone use of J&J’s ketamine-derived depression treatment  CNNFDA allows standalone use of nasal spray antidepressant Spravato (esketamine) : Shots - Health News  NPRFDA approves Johnson & Johnson’s nasal spray for depression as...